Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06916000
NA

Assessment of PENG Block as a Part of Multimodal Analgesia Following Hip Surgeries.

Sponsor: Ain Shams University

View on ClinicalTrials.gov

Summary

to study the effect of Pericapsular nerve group (PENG) block as a part of multimodal analgesia regimen for hip arthroplasties

Official title: Effect of Ultrasound Guided Pericapsular Nerve Group (PENG) Block on Perioperative Pain Management in Patients Undergoing Hip Arthroplasty

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2024-06-27

Completion Date

2025-06

Last Updated

2025-04-08

Healthy Volunteers

No

Conditions

Interventions

DRUG

Pericapsular nerve group (PENG) block

As a part of multimodal analgesia patients will receive 20 ml of 0.25% bupivcacaine according to the technique described by Giron-Arango. All patients will receive the same analgesic protocol, which included IV paracetamol 1000 mg BID and NSAIDs if no contra-indication; PO celecoxib 100 mg BID. Also if needed nalbuphine 5 mg IV will be given as bolus demand dose and when the NRS pain score was equal to or greater than 4 points.

OTHER

Patients will receive only other multimodal analgesics including LCFN block via 10 ml of 0.25% bupivacaine.

Patients will receive only other multimodal analgesics including LCFN block via 10 ml of 0.25% bupivacaine.

Locations (1)

Faculty of medicine, Ain Shams University

Abbasia, Cairo Governorate, Egypt